CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Shares withheld for taxes President and CEO gave up 2,678 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President and CFO gave up 507 shares (to pay taxes)
- 4 Grant or award Director acquired 1,991 shares (grant or award)
- 4 Grant or award Director acquired 1,991 shares (grant or award)
- 4 Grant or award SVP Ops & Prod Dev acquired 6,848 shares (grant or award)
- 4 Grant or award President and CEO acquired 37,280 shares (grant or award)
- 4 Grant or award Vice President and CFO acquired 12,451 shares (grant or award)
- 4 Grant or award Director acquired 1,991 shares (grant or award)
- 4 Grant or award Director acquired 2,584 shares (grant or award)
- 4 Grant or award SVP - New Bus Dev & Spec Sales acquired 12,451 shares (grant or award)
- 4 Grant or award Director acquired 1,991 shares (grant or award)
- 4 Open-market sale President and CEO sold 27,625 shares at an average $63.53 ($1,754,960)
- 4 Open-market sale SVP - New Bus Dev & Spec Sales sold 11,796 shares at an average $64.44 ($760,168)
- 5 Insider Annual Insider Trading Report
- 4 Exercise or conversion SVP - New Bus Dev & Spec Sales acquired 28,688 shares (option exercise)
- 4 Grant or award Director acquired 1,800 shares (grant or award)
- 4 Grant or award Director acquired 1,800 shares (grant or award)
- 4 Grant or award Director acquired 1,800 shares (grant or award)
- 4 Grant or award Director acquired 1,200 shares (grant or award)
- 4 Grant or award Director acquired 1,200 shares (grant or award)
Page 21 of 42 · 835 filings